PFE:ETR
Pfizer Inc
€25.11
arrow_upward
+1.21%(+0.30) 1D
Sep 28, 2:42:01 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PFE...
Open
€25.20
High
€25.27
Low
€25.10
Mkt. cap
163.41B
Avg. vol.
33.60K
Volume
27.45K
52-wk high
€25.36
52-wk low
€20.13
No. of employees
75K
Open
€25.20
High
€25.27
Low
€25.10
Mkt. cap
163.41B
Avg. vol.
33.60K
Volume
27.45K
52-wk high
€25.36
52-wk low
€20.13
No. of employees
75K
News stories
From web sources and news partners
scanx.trade
·
1 hour ago
Pfizer Q2FY26 Results: Revenue tops estimates, guidance raised by $500 million
Benzinga
·
2 hours ago
Full Transcript: Pfizer Q2 2026 Earnings Call
Investing.com Canada
·
2 hours ago
Pfizer to present oncology data at ESMO conference in October By Investing.com
Stock Titan
·
2 hours ago
Pfizer will give 11 cancer research talks in Madrid this October
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer Inc
CEOAlbert Bourla
Employees75K
Founded1849
HeadquartersNew York, New York, United States
SectorPharmaceutical industry
Websitepfizer.com